Trial Profile
A phase II study of TAK-114 in patients with ulcerative colitis
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 Jan 2015
Price :
$35
*
At a glance
- Drugs TAK 114 (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 28 Jan 2015 New trial record